Listerine Category I status for safety, efficacy recommended by FDA plaque subcmte.
This article was originally published in The Tan Sheet
Executive Summary
LISTERINE CATEGORY I STATUS FOR SAFETY, EFFICACY RECOMMENDED by FDA's Dental Products Panel Plaque Subcommittee at its Oct. 29-30 meeting in Gaithersburg, Md. The subcommittee agreed unanimously that the active ingredient combination of essential oils in Warner-Lambert's Listerine -- .064% thymol, .042% menthol, .092% eucalyptol and .06% menthol salicylate -- should be included in the OTC oral health care products monograph as a safe and effective treatment for plaque and gingivitis.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning